Form 8-K - Current report:
SEC Accession No. 0001829126-24-006437
Filing Date
2024-09-25
Accepted
2024-09-24 17:40:00
Documents
14
Period of Report
2024-09-23
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K nexalin_8k.htm   iXBRL 8-K 27908
  Complete submission text file 0001829126-24-006437.txt   246221

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE nxl-20240923.xsd EX-101.SCH 3751
3 XBRL DEFINITION FILE nxl-20240923_def.xml EX-101.DEF 26615
4 XBRL LABEL FILE nxl-20240923_lab.xml EX-101.LAB 36725
5 XBRL PRESENTATION FILE nxl-20240923_pre.xml EX-101.PRE 25239
16 EXTRACTED XBRL INSTANCE DOCUMENT nexalin_8k_htm.xml XML 5832
Mailing Address 1776 YORKTOWN SUITE 550 HOUSTON TX 77056
Business Address 1776 YORKTOWN SUITE 550 HOUSTON TX 77056 (832) 260-0222
Nexalin Technology, Inc. (Filer) CIK: 0001527352 (see all company filings)

EIN.: 275566468 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41507 | Film No.: 241320969
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)